VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells

Abstract

VX-984 efficiently inhibits NHEJ, resulting in compensatory increases in alternative repair pathways, increases DSBs, and appears to affect transformed cells preferentially.